Findings

What do systematic reviews say?

4,749 questions · 14,273 findings · 834 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3,655 · 25.6%GRADE not reported 2,115 · 14.8%Very low 3,646 · 25.5%Low 3,034 · 21.3%Moderate 1,503 · 10.5%High 320 · 2.2%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Lipid‐lowering agent vs placebo or no treatment

Progression of carotid stenosis · asymptomatic carotid stenosis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lipid‐lowering agent vs placebo or no treatment

Quality of life · asymptomatic carotid stenosis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antiplatelet agent vs placebo

Stroke‐related mortality · asymptomatic carotid stenosis

Antiplatelet agent showed no clear difference in stroke‐related mortality (CT scan or MRI) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 1.4 [0.54, 3.59]
1 study · 372 participants
Low

Antiplatelet agent vs placebo

Major bleeding · asymptomatic carotid stenosis

It is very uncertain whether antiplatelet agent changes major bleeding (not reported) compared with placebo (very low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 0.98 [0.06, 15.53]
1 study · 372 participants
Very low

Antiplatelet agent vs placebo

Progression of carotid stenosis · asymptomatic carotid stenosis

Antiplatelet agent showed no clear difference in progression of carotid stenosis (DUS/every 6 months) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 1.16 [0.79, 1.71]
1 study · 372 participants
Low

Antiplatelet agent vs placebo

Adverse events (not reported) · asymptomatic carotid stenosis

Antiplatelet agent showed no clear difference in adverse events (not reported) compared with placebo (low certainty).

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
RR 0.81 [0.41, 1.59]
1 study · 372 participants
Low

Antiplatelet agent vs placebo

Quality of life · asymptomatic carotid stenosis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antihypertensive agent vs placebo

Outcomes (measurement/time point) · asymptomatic carotid stenosis

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Adherence to treatment (number of participants undertaking physical activity) · people with CF

It is very uncertain whether the intervention changes adherence to treatment (number of participants undertaking physical… (very low certainty).

1 finding from 1 review

Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
RR 3.67 [1.24, 10.85]
1 study · 34 participants
Very low

Intervention not reported

Frequency of non‐hospitalised respiratory infection · people with CF

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

FEV1 % predicted (change from baseline) · people with CF

It is very uncertain whether the intervention changes FEV1 % predicted (change from baseline) (very low certainty).

1 finding from 1 review

Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Intervention not reported

FVC % predicted (change from baseline) · people with CF

It is very uncertain whether the intervention changes FVC % predicted (change from baseline) (very low certainty).

1 finding from 1 review

Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Intervention not reported

QoL (change from baseline) · people with CF

1 finding from 1 review

Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Intervention not reported

Exercise capacity (change from baseline) VO2 peak · people with CF

It is very uncertain whether the intervention changes exercise capacity (change from baseline) VO2 peak (very low certainty).

1 finding from 1 review

Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 34 participants
Very low

Motor imaging vs usual care

Prosthesis use · people with transtibial amputation due to peripheral arterial disease or diabetes

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 8 participants
GRADE not reported

Gait training protocol focused on impairment level vs gait training protocol focused on task level

Quality of life · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gait training protocol focused on impairment level vs gait training protocol focused on task level

Mobility · people with transtibial amputation due to peripheral arterial disease or diabetes

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
Very low

Gait training protocol focused on impairment level vs gait training protocol focused on task level

Phantom limb pain frequency · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Motor imaging vs usual care

Adverse events · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Motor imaging vs usual care

Mortality – all causes · people with transtibial amputation due to peripheral arterial disease or diabetes

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found